SODIUM VALPROATE ACUTELY INHIBITS LAMOTRIGINE METABOLISM

被引：209

作者：

YUEN, AWC ^{[1
]}

LAND, G ^{[1
]}

WEATHERLEY, BC ^{[1
]}

PECK, AW ^{[1
]}

机构：

[1] WELLCOME RES LABS,LANGLEY COURT,BECKENHAM BR3 3BS,KENT,ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1992年 / 33卷 / 05期

关键词：

SODIUM VALPROATE; LAMOTRIGINE; INTERACTION; GLUCURONIDE FORMATION;

D O I：

10.1111/j.1365-2125.1992.tb04079.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Concomitant administration of sodium valproate (VPA) reduced lamotrigine (LTG) total clearance by approximately 21% and increased elimination half-life and AUC. Reduced elimination occurred acutely within the first hour. Renal elimination of LTG was not impaired. The most probable explanation for this effect is hepatic competition between VPA and LTG for glucuronidation. Volume of distribution and parameters related to absorption, C(max) and t(max) were unchanged.

引用

页码：511 / 513

页数：3

共 15 条

[1] DOUBLE-BLIND CROSSOVER TRIAL OF LAMOTRIGINE (LAMICTAL) AS ADD-ON THERAPY IN INTRACTABLE EPILEPSY [J].

BINNIE, CD ;

DEBETS, RMC ;

ENGELSMAN, M ;

MEIJER, JWA ;

MEINARDI, H ;

OVERWEG, J ;

PECK, AW ;

VANWIERINGEN, A ;

YUEN, WC .

EPILEPSY RESEARCH, 1989, 4 (03) :222-229

[2] ACUTE EFFECTS OF LAMOTRIGINE (BW430C) IN PERSONS WITH EPILEPSY [J].

BINNIE, CD ;

BOAS, WV ;

KASTELEIJNNOLSTETRENITE, DGA ;

DEKORTE, RA ;

MEIJER, JWA ;

MEINARDI, H ;

MILLER, AA ;

OVERWEG, J ;

PECK, AW ;

VANWIERINGEN, A ;

YUEN, WC .

EPILEPSIA, 1986, 27 (03) :248-254

[3] MECHANISM OF ANTI-CONVULSANT ACTION OF VALPROATE [J].

CHAPMAN, A ;

KEANE, PE ;

MELDRUM, BS ;

SIMIAND, J ;

VERNIERES, JC .

PROGRESS IN NEUROBIOLOGY, 1982, 19 (04) :315-359

[4] LAMOTRIGINE, A NEW ANTICONVULSANT - PHARMACOKINETICS IN NORMAL HUMANS [J].

COHEN, AF ;

LAND, GS ;

BREIMER, DD ;

YUEN, WC ;

WINTON, C ;

PECK, AW .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :535-541

[5] ALTERATION OF ZIDOVUDINE PHARMACOKINETICS BY PROBENECID IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX [J].

DEMIRANDA, P ;

GOOD, SS ;

YARCHOAN, R ;

THOMAS, RV ;

BLUM, MR ;

MYERS, CE ;

BRODER, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (05) :494-500

[6] KINETIC EFFECTS OF MULTIPLE ORAL DOSES OF ACETAMINOPHEN ON A SINGLE ORAL DOSE OF LAMOTRIGINE [J].

DEPOT, M ;

POWELL, JR ;

MESSENHEIMER, JA ;

CLOUTIER, G ;

DALTON, MJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :346-355

[7]

HOWELL SR, 1986, J PHARMACOL EXP THER, V236, P610

[8] CONTROLLED TRIAL OF LAMOTRIGINE (LAMICTAL) FOR REFRACTORY PARTIAL SEIZURES [J].

JAWAD, S ;

RICHENS, A ;

GOODWIN, G ;

YUEN, WC .

EPILEPSIA, 1989, 30 (03) :356-363

[9] A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSSOVER ADD-ON TRIAL OF LAMOTRIGINE IN PATIENTS WITH TREATMENT-RESISTANT PARTIAL SEIZURES [J].

LOISEAU, P ;

YUEN, AWC ;

DUCHE, B ;

MENAGER, T ;

ARNEBES, MC .

EPILEPSY RESEARCH, 1990, 7 (02) :136-145

[10]

METZLER CM, 1974, BIOMETRICS, V30, P562

← 1 2 →